Cappuyns Intellectual Property Law
As a result of the pharma sector inquiry opened in January 2008, the European Commission issued three decisions for “pay-for-delay” competition law violations in the pharmaceutical industry: the Lundbeck decision re Citalopram in June 2013, the Fentanyl decision in December 2013 and the Servier decision re Perindopril in July 2014. An investigation of Cephalon and Teva concerning Modafinil is still pending.
Full articles are available only to LESI Members. Please login to view the PDF of this Les Nouvelles Article.
Not an LESI member? Find out how to join your regional LES society and gain access to all that your LES society and LESI has to offer.